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Glucocorticoid treatment is often linked to increased whole-body energy
expenditure and hypermetabolism. Glucocorticoids affect mitochondrial energy
production, notably in the liver, where they lead to mitochondrial uncoupling
reducing the efficacy of oxidative phosphorylation. However, the signaling
pathways involved in these phenomena are poorly understood. Here we treated
HepG2 cells with dexamethasone for different times and, by using different
combinations of inhibitors, we showed that dexamethasone treatment leads to
recruitment of two main signaling pathways. The first one involves a G-protein
coupled membrane glucocorticoid binding site and rapidly decreases complexes I
and II activities while complex III activity is upregulated in a p38MAPK dependent
mechanism. The second one implies the classical cytosolic glucocorticoid receptor
and triggers long-term transcriptional increases of respiration rates and of complex
IV activity and quantity. We concluded that mitochondria are the target of multiple
dexamethasone-induced regulatory pathways that are set up gradually after the
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